| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |